TABLE OF CONTENTS
Volume 37, Issue 8 (April (2) 2006)
Original Articles
Stem Cell Procurement
Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation FREE
V Pavone, F Gaudio, G Console, U Vitolo, P Iacopino, A Guarini, V Liso, T Perrone and A Liso
Bone Marrow Transplant 37: 719-724; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705298
The VAD chemotherapy regimen plus a G-CSF dose of 10 
g/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 g/kg for progenitor cell mobilization: results from a monocentric study of 82 patients FREE
F Lefrère, S Zohar, D Ghez, R Delarue, F Audat, F Suarez, O Hermine, G Damaj, N Maillard, J A Ribeil, M Azagury, R Misbahi, K Jondeau, M Cavazzana-Calvo, L Dal Cortivo and B Varet
Bone Marrow Transplant 37: 725-729; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705308
Autografting
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients FREE
D O'Shea, C Giles, E Terpos, J Perz, M Politou, V Sana, K Naresh, I Lampert, D Samson, S Narat, E Kanfer, E Olavarria, J F Apperley and A Rahemtulla
Bone Marrow Transplant 37: 731-737; advance online publication, February 27, 2006; doi:10.1038/sj.bmt.1705307
Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas FREE
M Mabed and T Al-Kgodary
Bone Marrow Transplant 37: 739-743; advance online publication, February 27, 2006; doi:10.1038/sj.bmt.1705314
Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia FREE
R Kumar, S Prem, M Mahapatra, T Seth, D R Chowdhary, P Mishra, L Pillai, A M V R Narendra, N K Mehra, R Saxena and V P Choudhry
Bone Marrow Transplant 37: 745-749; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705321
Post-Transplant Events
Developing an algorithm of informative markers for evaluation of chimerism after allogeneic bone marrow transplantation FREE
S Sellathamby, P Balasubramanian, S Sivalingam, R V Shaji, V Mathews, B George, A Viswabandya, A Srivastava and M Chandy
Bone Marrow Transplant 37: 751-755; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705317
A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation FREE
S Elad, A Ackerstein, M Bitan, M Y Shapira, I Resnick, B Gesundheit, Y Cohen, O Diss, D Barak, L Dray and R Or
Bone Marrow Transplant 37: 757-762; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705331
T-lymphocyte reconstitution following rigorously T-cell-depleted versus unmodified autologous stem cell transplants FREE
P A W te Boekhorst, C H J Lamers, M R Schipperus, R Q Hintzen, B van der Holt, J J Cornelissen, B Löwenberg and J W Gratama
Bone Marrow Transplant 37: 763-772; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705333
Graft-Versus-Host Desease
Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate FREE
N Murphy, M Diviney, J Szer, P Bardy, A Grigg, R Hoyt, B King, L MacGregor, R Holdsworth, J McCluskey and B D Tait
Bone Marrow Transplant 37: 773-779; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705319
Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels FREE
A Elefante, J Muindi, K West, L Dunford, S Abel, P Paplham, K Brown, T Hahn, S Padmanabhan, M Battiwalla and P L McCarthy Jr
Bone Marrow Transplant 37: 781-784; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705320
Letters to the Editor
Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia FREE
E Ozdemir and J J Molldrem
Bone Marrow Transplant 37: 785-786; advance online publication, February 27, 2006; doi:10.1038/sj.bmt.1705309
Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient FREE
K Shimada, H Narimatsu, Y Morishita, A Kohno, S Saito and Y Kato
Bone Marrow Transplant 37: 787-788; advance online publication, February 27, 2006; doi:10.1038/sj.bmt.1705312
Donor origin of Graves disease in a BMT recipient: evidence from FISH studies of thyroid tissue FREE
K Drabko, D Winnicka, A Gaworczyk, I Be
-Skowronek, D Skomra and J R Kowalczyk
Bone Marrow Transplant 37: 789-791; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705316
Pertussis: should we vaccinate post transplant? FREE
G Kochethu, F J Clark and C F Craddock
Bone Marrow Transplant 37: 793-794; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705318
Second donation of bone marrow: results from the Japan Marrow Donor Program (JMDP) FREE
H Akiyama, M Hara, M Hino, H Sao, Y Hoshi, H Ohto and S Kai for Safety Committee of the Japan Marrow Donor Program
Bone Marrow Transplant 37: 795-796; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705322
Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma; successful treatment with high-dose intravenous immunoglobulin FREE
M Ostronoff, F Ostronoff, M Coutinho, R Calixto, A P Souto Maior, A Sucupira, R Florencio and C Tagliari
Bone Marrow Transplant 37: 797-798; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705329
Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation FREE
K Robien, M M Schubert, T Chay, J Bigler, R Storb, Y Yasui, J D Potter and C M Ulrich
Bone Marrow Transplant 37: 799-800; advance online publication, February 27, 2006; doi:10.1038/sj.bmt.1705330
Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia FREE
F Pieroni, F M Oliveira, R A Panepucci, J C Voltarelli, B P Simões and R P Falcão
Bone Marrow Transplant 37: 801-802; advance online publication, February 27, 2006; doi:10.1038/sj.bmt.1705332
Unrelated cord blood transplantation after myeloablative conditioning in patients with acute leukemia aged between 50 and 55 years FREE
T Konuma, J Ooi, S Takahashi, A Tomonari, M Uchiyama, K Fukuno, N Tsukada, T Iseki, A Tojo and S Asano
Bone Marrow Transplant 37: 803-804; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705334
Iron-overload in long-term survivors of hematopoietic transplantation FREE
R Kamble and M Mims
Bone Marrow Transplant 37: 805-806; advance online publication, March 6, 2006; doi:10.1038/sj.bmt.1705335
Unrelated bone marrow transplantation using a reduced intensity-conditioning regimen in leukocyte adhesion deficiency FREE
D Takahashi, Y Nagatoshi, Y Saito, J Inagaki, J Nagayama, Y Shinkoda, K Fujita and J Okamura
Bone Marrow Transplant 37: 807-808; advance online publication, March 13, 2006; doi:10.1038/sj.bmt.1705336
